Table 1.
Demographic data for cilostazol cohort and comparison cohort (n = 9148)
| Variables | Comparison cohort (n = 6861) | Cilostazol cohort (n = 2287) | p-value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Age (years) | |||||
| < 65 | 2425 | 35.3 | 797 | 34.8 | 0.667 |
| ≥ 65 | 4436 | 64.7 | 1490 | 65.2 | |
| Sex | |||||
| Female | 3274 | 47.7 | 1067 | 46.7 | 0.378 |
| Male | 3587 | 52.3 | 1220 | 53.3 | |
| Comorbidities | |||||
| Diabetes | 4047 | 59.0 | 1358 | 59.4 | 0.740 |
| Hyperlipidemia | 3483 | 50.8 | 1174 | 51.3 | 0.638 |
| Hypertension | 5540 | 80.7 | 1808 | 79.1 | 0.078 |
| Depression | 967 | 14.1 | 296 | 12.9 | 0.167 |
| Ischemic heart disease | 833 | 12.1 | 308 | 13.5 | 0.096 |
| Cerebral vascular disease | 1416 | 20.6 | 478 | 20.9 | 0.789 |
| Charlson's index score | |||||
| ≤ 1 | 2019 | 29.4 | 681 | 29.8 | 0.696 |
| 2 | 1409 | 20.5 | 484 | 21.2 | |
| ≥ 3 | 3433 | 50.0 | 1122 | 49.1 | |
| Medication | |||||
| Anticoagulant agents | 115 | 1.7 | 45 | 2.0 | 0.357 |
| Antiplatetet agents | 1234 | 18.0 | 441 | 19.3 | 0.165 |
| Antidiabetic agents | 3174 | 46.3 | 1046 | 45.7 | 0.663 |
| Antihypertension agents | 4866 | 70.9 | 1595 | 69.7 | 0.283 |
| Statin | 1529 | 22.3 | 539 | 23.6 | 0.204 |